For the second time this month, there’s promising news from a COVID-19 vaccine candidate. Moderna says preliminary phase three trial data shows its coronavirus vaccine is nearly 95% effective in preventing COVID-19.
For the second time this month, there’s promising news from a COVID-19 vaccine candidate. Moderna says preliminary phase three trial data shows its coronavirus vaccine is nearly 95% effective in preventing COVID-19.